Abbott Acquires Cardiovascular Systems, Inc.
February 8, 2023
Abbott entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI), a medical device company focused on atherectomy systems for treating peripheral and coronary artery disease. Under the terms of the deal, CSI stockholders will receive $20 per share, for an expected total equity value of approximately $890 million.
- Buyers
- Abbott
- Targets
- Cardiovascular Systems, Inc.
- Sellers
- CSI stockholders
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Novartis AG to Acquire Avidity Biosciences in $12B Deal (with Precision Cardiology SpinCo)
October 26, 2025
Biotechnology
Novartis AG has entered into a definitive merger agreement to acquire Avidity Biosciences for $72.00 per share in cash, valuing Avidity at approximately $12.0 billion. The transaction follows the planned separation of Avidity’s early-stage precision cardiology programs into a new publicly traded company (“SpinCo”), which is expected to begin trading after the spin-off.
-
Johnson & Johnson Completes Acquisition of Abiomed
December 22, 2022
Medical Devices
Johnson & Johnson completed its acquisition of Abiomed through a tender offer and subsequent merger, for an upfront payment of $380.00 per share in cash (enterprise value ~ $16.6 billion), plus a non-tradeable contingent value right (CVR) up to $35.00 per share based on milestones. Abiomed will operate as a standalone business within Johnson & Johnson’s MedTech segment.
-
Ra Medical Systems Acquires Catheter Precision in Stock-for-Stock Reverse Merger
September 12, 2022
Medical Devices
Ra Medical Systems entered into a definitive agreement to acquire privately held Catheter Precision through a stock-for-stock reverse merger in which Catheter Precision will become a wholly owned subsidiary. The combined company will focus on the cardiac electrophysiology market and is expected to close before the end of 2022, subject to shareholder approval and other customary closing conditions.
-
Haemonetics Acquires Cardiva Medical
January 20, 2021
Medical Devices
Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.
-
Keystone Heart Acquires 510 Kardiac Devices, Inc.
June 16, 2020
Medical Devices
Keystone Heart Ltd., a Venus Medtech company, has acquired 510 Kardiac Devices, Inc., the developer of the Lim Transseptal System. The acquisition expands Keystone Heart's structural heart portfolio by adding a transseptal access system designed for left-sided structural heart and electrophysiology procedures and will support commercial introduction in the US and Europe.
-
Circle Cardiovascular Imaging Acquires Corstem Inc.
February 7, 2019
Healthcare Services
Circle Cardiovascular Imaging Inc. has acquired Montreal-based AI cardiac imaging developer Corstem Inc. Corstem’s automatic, fully-quantitative myocardial perfusion technology will be integrated into Circle’s cvi42 platform to expand its cardiac MRI perfusion capabilities and accelerate global clinical deployment.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.